The KLHL40 gene helps build and steady the proteins that let skeletal muscles form and contract normally. This gene plays an important role in muscle strength before birth and after delivery. If it does not work properly, babies may have very weak muscles, reduced movement before birth, feeding or breathing problems, and a congenital muscle condition called nemaline myopathy. Severe variants can cause major symptoms from birth.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or managing processes in the body. Some carry the information needed to produce proteins, the parts of cells that do the work. Others mainly help regulate when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
KLHL40Gene function
What if the gene works
The KLHL40 gene helps build and stabilize skeletal muscle fibers. This supports normal muscle strength and movement by helping muscles contract in a coordinated way.
Risk
What if the gene does not work
Variants in the KLHL40 gene usually cause nemaline myopathy, with low tone, weakness, and feeding or breathing problems. Milder to more severe variants can influence how early symptoms appear and how strongly muscles are affected.
Treatment
What does that mean for your treatment
No KLHL40-specific treatment or drug selection approach is currently established for pathogenic variants in the KLHL40 gene. Management is supportive and guided by breathing, feeding, and movement needs rather than by the KLHL40 variant itself.
Conditions associated with KLHL40
Gene function
What if the gene works
The KLHL40 gene is especially active in skeletal muscles, the muscles you use for posture, breathing, and movement. It helps muscle cells build and maintain the tiny structures that let them contract in a smooth, coordinated way. Understanding how the KLHL40 gene supports muscle development helps explain healthy muscle growth and day to day strength.
Inside developing muscle cells, the KLHL40 gene helps organize the parts that later shorten and relax during movement. This supports normal skeletal muscle formation before and after birth.
KLHL40 helps steady key muscle proteins that build thin filaments, the fine strands muscle fibers use to contract. This keeps important muscle building parts in place as fibers mature.
It helps muscle cells assemble sarcomeres (tiny repeating units that power contraction) in an orderly pattern. That structure supports smooth, controlled muscle force during everyday movement.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help account for normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
KLHL40 gene variants often lower the amount or stability of the KLHL40 protein, so key muscle proteins are not kept in place and muscle fibers develop poorly. Some changes partly reduce protein function, while more severe variants can shorten the protein or stop it from being made at all. This spectrum helps explain how KLHL40 gene variants affect muscle protein stability and why some people develop nemaline myopathy earlier and with more marked weakness than others.
How variants are linked to conditions
The link between the KLHL40 gene and nemaline myopathy is well established. Pathogenic variants in the KLHL40 gene cause a rare inherited muscle condition that often starts before birth or in early infancy. It is associated with reduced fetal movement, low muscle tone, weakness, breathing problems, and sometimes joint contractures at birth. Most affected people have disease-causing variants in both copies of the gene, which can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology, and they are common across the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant connected with a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KLHL40, risk is mainly determined by inheritance: a child is affected when they inherit two changed copies of the gene, one from each parent. Risk can be higher in families with a known KLHL40 change and in groups where certain inherited changes are more common. There is not enough evidence to say that lifestyle changes lower this genetic risk.
Inheritance of KLHL40 variants
KLHL40-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one KLHL40 gene variant from each parent, and the parents are typically healthy carriers. When both parents carry a variant in the KLHL40 gene, each pregnancy has a 25% chance of the child inheriting both changed copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how KLHL40 gene variants are inherited usually becomes clear only when both sides of the family pass on the same condition-linked gene change.
What does my KLHL40 result mean for my family?
Changes in the KLHL40 gene are linked to a muscle condition that usually runs in families in a recessive pattern. For family members, this often means parents can be healthy carriers, and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change is present, especially if there is a family history of severe muscle weakness starting at birth or in early infancy.
Genetic information
Genetic testing
How you find out about variants
KLHL40 genetic testing usually uses a blood or saliva sample to read the KLHL40 gene and look for variants linked to congenital muscle conditions such as nemaline myopathy. Results may identify a disease causing variant, show no relevant change, or find a variant of uncertain significance, which means the lab found a change but its health effect is not yet clear.
When should I consider getting a genetic test?
Consider KLHL40 genetic testing when a baby or child has signs of a severe inherited muscle condition, especially less movement during pregnancy or marked weakness, floppiness, feeding trouble, or breathing problems at birth. It can also help families with a known KLHL40 change understand the chance of it happening again in a future pregnancy.
A genetic result is only one part of your health story
A genetic result can provide meaningful information, but what it tells you depends on the condition and on the type of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it into tissues, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medication. It looks at gene and drug patterns to better understand why the same treatment may work differently from one person to another. For many medicines, genes help shape both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. If you want to learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the KLHL40 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines work, so any concerns about symptoms, treatment, or side effects are best discussed with your doctor, especially before starting or changing a medication.
History
The KLHL40 gene entered medical genetics fairly recently through research on babies born with a severe muscle condition later classified within nemaline myopathy. In 2013, studies using newer DNA sequencing methods linked harmful variants in the KLHL40 gene to this condition in affected families from different parts of the world. This helped explain cases that had previously been recognized by muscle weakness and breathing problems but had no clear genetic cause. From these first observations, research expanded steadily. As more families were studied, the KLHL40 gene became established as an important cause of a rare inherited muscle condition, helping doctors improve diagnosis and family counseling.